$CING
Cingulate Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Kansas City, KS
CING chart
What traders are saying about $CING
Latest postsCingulate Inc. news
- Brain Glutamate Networks Differ in First-Episode Psychosis, Seven-Tesla Study Finds
Bioengineer.org ·
- Intraoperative Subcallosal Cingulate Local Field Potential Spectral Analysis During Emotion-Evoking Music in Treatment-Resistant Depression With Multitarget Deep Brain Stimulation: A Case Report
Cureus ·
- Attention Deficit Hyperactivity Disorder Pipeline Update 2026: Clinical Development Status, Collaborations, and Key Companies to Watch | Afecta Pharma, ABVC BioPharma, Mind Medicine, Neurocentria
StreetInsider ·
- New Research Finds Daily Peanut Consumption Benefits Brain's Response to Insulin in Memory Related Regions
Eastern Progress ·
- Scientists Discover That Eating Peanuts Every Day May Help Protect the Aging Brain
SciTechDaily ·
- Distinct Calcium Response Signatures Separate Itch and Pain in Brain Neurons
Bioengineer.org ·
- How Autism Reduces Sensitivity to Decision Feedback
Mirage News ·
- Cingulate Inc. Estimates – NASDAQ:CING
TradingView ·
- Does It Look Painful or Disgusting? Ask Your Parietal and Cingulate Cortex
Journal of Neuroscience ·
- Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma
Yahoo Finance ·
- CING: Second Quarter Results
Yahoo Finance ·
- Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness
Yahoo Finance ·
Cingulate Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$22.4M | -$16.6M | -$23.5M | -$17.7M |
| Diluted EPS | $-4.44 | $-10.86 | $-311.99 | $-29.35 |
| Total assets (year end) | $15.1M | $14.9M | $3.5M | $11.4M |
| Cash and equivalents (year end) | $11.0M | $12.2M | $52,416 | $5.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Cingulate Inc.
- Ticker
- CING (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Kansas City, KS
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1862150
- Former names
- Cingulate Inc.
Frequently asked questions
What exchange is Cingulate Inc. listed on?
Cingulate Inc. trades on the Nasdaq under the ticker symbol CING.
What industry is Cingulate Inc. in?
Cingulate Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Cingulate Inc. headquartered?
Cingulate Inc.'s business address on file with the SEC is in Kansas City, KS.
When does Cingulate Inc.'s fiscal year end?
Cingulate Inc.'s fiscal year ends on December 31.